Nichols & Pratt Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$340K Hold
1,043
0.02% 89
2025
Q1
$282K Sell
1,043
-332
-24% -$89.6K 0.02% 87
2024
Q4
$324K Hold
1,375
0.02% 86
2024
Q3
$378K Buy
+1,375
New +$378K 0.02% 87